Novel method enables RNA detection with Cas12 nucleases

FHS
July 17, 2024
2:29 pm

CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics.

MacroGenics investigates three patient deaths in Phase 2 prostate cancer drug trial

MacroGenics reported on Thursday afternoon that three patients died in a mid-stage trial of its antibody-drug conjugate for prostate cancer. Two participants died due to

May 11, 2024

Why Patient Engagement Must Be at the Center of Value-Based Care

Dave Bennett, Executive Vice President – Healthcare, pCare by Uniguest In the dynamic and ever-changing landscape of the healthcare industry, patient engagement continues to emerge

July 1, 2024

Lexicon ends commercial work to focus on R&D

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.